HRP20020735A2 - Tablet obtained by direct compression comprising 4-amino-1-hydroxybutylidene-1,1-bisphosphonic acid as active ingredient - Google Patents

Tablet obtained by direct compression comprising 4-amino-1-hydroxybutylidene-1,1-bisphosphonic acid as active ingredient

Info

Publication number
HRP20020735A2
HRP20020735A2 HRP20020735A HRP20020735A2 HR P20020735 A2 HRP20020735 A2 HR P20020735A2 HR P20020735 A HRP20020735 A HR P20020735A HR P20020735 A2 HRP20020735 A2 HR P20020735A2
Authority
HR
Croatia
Prior art keywords
hydroxybutylidene
amino
active ingredient
direct compression
bisphosphonic acid
Prior art date
Application number
Other languages
English (en)
Inventor
Dagmar Jaueprovs
Original Assignee
Leciva
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=5471285&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HRP20020735(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Leciva filed Critical Leciva
Publication of HRP20020735A2 publication Critical patent/HRP20020735A2/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/662—Phosphorus acids or esters thereof having P—C bonds, e.g. foscarnet, trichlorfon
    • A61K31/663—Compounds having two or more phosphorus acid groups or esters thereof, e.g. clodronic acid, pamidronic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Biophysics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Inorganic Chemistry (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
HRP20020735 2000-07-11 2001-06-29 Tablet obtained by direct compression comprising 4-amino-1-hydroxybutylidene-1,1-bisphosphonic acid as active ingredient HRP20020735A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CZ20002567A CZ20002567A3 (cs) 2000-07-11 2000-07-11 Tableta vyrobitelná přímým tabletováním, obsahující aktivní látku kyselinu 4-amino-1-hydroxybutyliden-1,1-bisfosfonovou, a způsob její výroby
PCT/CZ2001/000037 WO2002003963A1 (en) 2000-07-11 2001-06-29 Tablet obtained by direct compression comprising 4-amino-1-hydroxybutylidene-1, 1-bisphosphonic acid as active ingredient

Publications (1)

Publication Number Publication Date
HRP20020735A2 true HRP20020735A2 (en) 2004-12-31

Family

ID=5471285

Family Applications (1)

Application Number Title Priority Date Filing Date
HRP20020735 HRP20020735A2 (en) 2000-07-11 2001-06-29 Tablet obtained by direct compression comprising 4-amino-1-hydroxybutylidene-1,1-bisphosphonic acid as active ingredient

Country Status (17)

Country Link
US (1) US7198802B2 (de)
EP (1) EP1299088B1 (de)
AT (1) ATE331502T1 (de)
AU (1) AU2001270454A1 (de)
BG (1) BG107520A (de)
CA (1) CA2415630A1 (de)
CZ (1) CZ20002567A3 (de)
DE (1) DE60121166D1 (de)
EE (1) EE200300017A (de)
HR (1) HRP20020735A2 (de)
HU (1) HUP0301072A3 (de)
PL (1) PL360872A1 (de)
RU (1) RU2279273C2 (de)
SK (1) SK283249B6 (de)
UA (1) UA73784C2 (de)
WO (1) WO2002003963A1 (de)
YU (1) YU77702A (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6827718B2 (en) 2001-08-14 2004-12-07 Scimed Life Systems, Inc. Method of and apparatus for positioning and maintaining the position of endoscopic instruments
AU2003230805A1 (en) * 2002-04-05 2003-10-27 Penwest Pharmaceuticals Co. Sustained release metoprolol formulations
GR1004331B (el) * 2002-10-07 2003-09-05 Verisfield (Uk) Ltd Νεες φαρμακευτικες συνθεσεις που περιεχουν αλας αλενδρονικου οξεος
WO2006018033A1 (en) * 2004-08-20 2006-02-23 Mepha Ag Formulations of bisphosphonates
WO2006046100A1 (en) * 2004-10-25 2006-05-04 Ranbaxy Laboratories Limited Pharmaceutical composition of alendronic acid
WO2006054165A1 (en) * 2004-11-19 2006-05-26 Ranbaxy Laboratories Limited Pharmaceutical compositions of alendronic acid and processes for their preparation
US9050391B2 (en) 2005-10-27 2015-06-09 Nexilis Ag Implant and production method for said implant
FR2918567B1 (fr) * 2007-07-11 2012-08-03 Pf Medicament Composition pharmaceutique stable d'un sel hydrosoluble de vinorelbine.
US20110229566A1 (en) * 2008-08-22 2011-09-22 Yatendra Kumar Gupta Single Unit Oral Dose Pharmaceutical Composition Comprising Levodopa, Carbidopa And Entacapone Or Salts Thereof
WO2010133629A1 (en) * 2009-05-19 2010-11-25 Grindeks, A Joint Stock Company Stable pharmaceutical composition of fludarabine phosphate
EP2512455B8 (de) 2009-12-18 2014-07-23 FrieslandCampina Nederland Holding B.V. Co-verarbeitete tablettenunterstützungszusammensetzung sowie ihre herstellung und verwendung
WO2023025672A1 (en) 2021-08-25 2023-03-02 Basf Se Direct tableting auxiliary composition

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5358941A (en) * 1992-12-02 1994-10-25 Merck & Co., Inc. Dry mix formulation for bisphosphonic acids with lactose
CZ287984B6 (cs) * 1993-05-15 2001-03-14 Roche Diagnostics Gmbh Tableta se zlepšenou biodostupností účinné látky, kyseliny klodronové, a způsob její výroby
US5853759A (en) * 1996-05-17 1998-12-29 Merck & Co.. Inc. Effervescent alendronate formulation
EP1035869A1 (de) * 1997-03-26 2000-09-20 Sepracor, Inc. Chemisch und thermisch stabile norastemizol formulierungen
PL358593A1 (en) * 2000-04-07 2004-08-09 Pfizer Products Inc. Estrogen agonist/antagonist metabolites

Also Published As

Publication number Publication date
RU2279273C2 (ru) 2006-07-10
UA73784C2 (en) 2005-09-15
DE60121166D1 (de) 2006-08-10
BG107520A (bg) 2003-06-30
SK5112001A3 (en) 2002-02-05
CZ289261B6 (cs) 2001-12-12
AU2001270454A1 (en) 2002-01-21
EP1299088B1 (de) 2006-06-28
EE200300017A (et) 2004-10-15
CA2415630A1 (en) 2002-01-17
EP1299088A1 (de) 2003-04-09
HUP0301072A2 (hu) 2003-08-28
CZ20002567A3 (cs) 2001-12-12
SK283249B6 (sk) 2003-04-01
YU77702A (sh) 2006-05-25
PL360872A1 (en) 2004-09-20
HUP0301072A3 (en) 2005-07-28
WO2002003963A1 (en) 2002-01-17
US20030161878A1 (en) 2003-08-28
ATE331502T1 (de) 2006-07-15
US7198802B2 (en) 2007-04-03

Similar Documents

Publication Publication Date Title
YU77702A (sh) Tableta dobijena direktnom kompresijom koja kao aktivni sastojak obuhvata 4-amino-1-hidroksibutiliden-1,1-bisfosfinsku kiselinu
TW200505406A (en) Pharmaceutical compositions comprising a basic respectively acidic drug compound, a surfactant and a physiologically tolerable water-soluble acid respectively base
WO2003028703A3 (en) Immediate release tablet
USD463557S1 (en) Bone plate
PE20001036A1 (es) Tabletas bioadhesivas para hidratacion progresiva y metodos para su elaboracion y uso
CA2422359A1 (en) Combretastatin a-4 phosphate prodrug salts with nitrogen-containing compounds
GR960300064T1 (en) Fluoxetine Pharmaceutical formulations
PT1317419E (pt) Compostos e composições de ácido cianofenoxicarboxílico para administrar agentes activos
WO2003037860A3 (en) Purine analogs having hsp90-inhibiting activity
IT1271904B (it) Complesso di calcio per arma da fuoco
CA2322315A1 (en) Fast disintegrating tablets
WO2002009719A1 (en) Antitumor agents
ITMI992748A0 (it) Scarpa con suola presentante una parte per l'avampiede suddivisa in al meno due parti
NZ527157A (en) Compositions for delivering bisphosphonates
GEP20094627B (en) High drug load tablet
MXPA02003977A (es) Inhibidores de adhesion de celula mediada por al°2.
AU2001296865A1 (en) (5-(2-hydroxy-4-chlorobenzoyl) aminovaleric acid and salts thereof and compositions containing the same for delivering active agents
CA2200568A1 (fr) Association therapeutique vitamino-calcique sous forme galenique unitaire de comprimes, son procede d'obtention et son utilisation
BG106927A (en) Matrix tablet for prolonged release of trimetazidine after oral administration
BG105436A (en) Pharmaceutical compositions comprising entacapone or nitecapone as well as a cross-linked cellulpse derivative
WO2000021910A3 (en) 1,2-disubstituted cyclopropanes
MXPA04001355A (es) Calzado para mejorar la marcha natural.
CA2326339A1 (en) Use of dexmedetomidine for icu sedation
AU4249700A (en) Hydroxamic acid derivative
HK1052872A1 (zh) 微团

Legal Events

Date Code Title Description
A1OB Publication of a patent application
AIPI Request for the grant of a patent on the basis of a substantive examination of a patent application
PNAN Change of the applicant name, address/residence

Owner name: ZENTIVA, A.S., CZ

ODBC Application rejected